Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Inivata Ltd.
Minute Insight: Inivata's RaDaR Assay Study Yields Encouraging Results
RaDaR, a test for head and neck squamous cell carcinoma, demonstrated high efficacy in a new study.
Inivata Continues Trials Of Its Liquid Biopsy Platform
The partnership with the Princess Margaret Cancer Center will support two studies of liquid biopsy testing for lung cancer.
Orange County Entrepreneur Banks On Data-Based Approach To Detect, Treat Diseases
IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.
Big Money Spent On Liquid Biopsy Technology In 2021
Deal-making and financing activities are on the rise for liquid biopsy diagnostic products in 2021 despite questions remaining around whether the technology can unseat standard-of-care biomarker and imaging tests.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.